The type 1 diabetes population had the following characteristics: the mean age was 39 years, 54% were male, and mean body mass index (BMI) was 25.1 kg/m2
Many insurance plans cover office visits, lab testing, and FDA-approved hormone therapies when treatment is deemed medically necessary
8 It is unclear whether this retinopathy is a true adverse effect related to a molecule-specific effect of semaglutide or whether it relates to rapid marked reduction in glucose, such as originally described in the Diabetes Control and Complications Trial
Epithelial cells (non renal) testing is not performed if protein, WBC esterase, occult blood, and nitrites are all negative
The legal access landscape shifted meaningfully in April 2026 when the FDA removed both peptides from its Category 2 restricted list
Ozempic and Rybelsus are FDA-approved for this purpose